Here's Wouldn't Touch Canopy: Why I Pass in 2026 and Beyond
Cannabis stocks remain volatile and Canopy Growth sits at a crossroads in 2026. This article explains why many invest...
Auto investing in Dividend Aristocrats ETF helps maintain discipline and harness compounding. Here's why this approach supports steady, long-term growth.
21,043 articlesCannabis stocks remain volatile and Canopy Growth sits at a crossroads in 2026. This article explains why many invest...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
D-Wave Quantum stock swung wildly on momentum and policy headlines, then reversed hard. This guide breaks down what h...
Bitcoin's recent surge has sparked talk of a new bull leg. Yet Wintermute's warning — wintermute cautions 'relief ral...
ASML delivered a powerhouse quarter that suggests AI infrastructure spending remains resilient. With Intel set to rep...
The chatter around KLAC stock is loud, but smart investors want clarity. This guide breaks down why KLAC is in focus,...
A new AI-driven supercycle is unfolding, but you don’t need to chase dramatic bets. This guide explains how agentic A...
A major fund recently sold its entire NIO position for about $79.8 million. This article breaks down what happened, w...
In 2024, medicare paid $12.3 billion for a cluster of services that are now facing tighter coverage. This shift could...
The SpaceX IPO hype could pull even the most skeptical investors into ownership. This guide explains why even those a...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
Micron Technology stock sits at the crossroads of AI memory demand and a broader semiconductor pullback. This guide w...